James Hall
Directeur Général chez Betagenon Sweden AB
Postes actifs de James Hall
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Betagenon Sweden AB
 Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Directeur Général | 27/05/2021 | - |
Historique de carrière de James Hall
Formation de James Hall
| University of Oxford | Doctorate Degree |
Statistiques
Internationale
| Suède | 2 |
| Royaume-Uni | 2 |
Opérationnelle
| Chief Executive Officer | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Betagenon Sweden AB
Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Health Technology |
- Bourse
- Insiders
- James Hall
- Expérience
